Danaher Corporation $DHR Shares Newly Bought by Holcombe Financial Inc.

Posted by Brenda Bartman on Oct 17th, 2026

Holcombe Financial Inc. purchased a new stake in shares of Danaher Corporation (NYSE:DHR – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 5,140 shares of the conglomerate’s stock, valued at approximately $1,139,000. Danaher comprises approximately 0.6% of Holcombe Financial Inc.’s holdings, making the stock its 19th biggest position.

Several other large investors have also made changes to their positions in the company. Main Street Group LTD acquired a new position in shares of Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC bought a new position in shares of Danaher during the 2nd quarter worth about $25,000. Marquette Asset Management LLC increased its stake in Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 73 shares during the period. Evolution Wealth Management Inc. increased its stake in Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 104 shares during the period. Finally, Field & Main Bank acquired a new position in Danaher in the 2nd quarter valued at approximately $29,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE:DHR traded down $2.63 during trading hours on Friday, reaching $228.87. The company had a trading volume of 3,516,366 shares, compared to its average volume of 4,667,069. The stock has a 50-day moving average of $214.04 and a two-hundred day moving average of $195.97. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a market capitalization of $160.89 billion, a PE ratio of 40.65, a PEG ratio of 2.91 and a beta of 0.76. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.77 EPS. Analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Analyst Ratings Changes

DHR has been the topic of several recent research reports. Barclays lifted their price objective on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a report on Wednesday, October 7th. The Goldman Sachs Group lifted their price target on shares of Danaher from $210.00 to $250.00 and gave the stock a “buy” rating in a research note on Monday, September 21st. Guggenheim boosted their price target on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Weiss Ratings raised shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Finally, Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $235.41.

Read Our Latest Analysis on Danaher

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.